{"id":"https://openalex.org/W4322769111","doi":"https://doi.org/10.1158/1538-7445.sabcs22-pd17-05","title":"Abstract PD17-05: Development and Validation of a Composite Biomarker Predictive of Palbociclib + Endocrine Treatment Benefit in Early Breast Cancer: PENELOPE-B and PALLAS Trials","display_name":"Abstract PD17-05: Development and Validation of a Composite Biomarker Predictive of Palbociclib + Endocrine Treatment Benefit in Early Breast Cancer: PENELOPE-B and PALLAS Trials","publication_year":2023,"publication_date":"2023-03-01","ids":{"openalex":"https://openalex.org/W4322769111","doi":"https://doi.org/10.1158/1538-7445.sabcs22-pd17-05"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.sabcs22-pd17-05","doi":"https://doi.org/10.1158/1538-7445.sabcs22-pd17-05","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.sabcs22-pd17-05","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5087559224","display_name":"Sibylle Loibl","orcid":"https://orcid.org/0000-0001-6488-4958","observed_orcids":["https://orcid.org/0000-0001-6488-4958"]},"institutions":[{"id":"https://openalex.org/I4210130803","display_name":"German Breast Group","ror":"https://ror.org/03c8hnh70","country_code":"DE","type":"nonprofit","lineage":["https://openalex.org/I4210130803"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Sibylle Loibl","raw_affiliation_strings":["1German Breast Group, Neu-isenburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1German Breast Group, Neu-isenburg, Germany","institution_ids":["https://openalex.org/I4210130803"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033698551","display_name":"Carsten Denkert","orcid":"https://orcid.org/0000-0002-2249-0982","observed_orcids":["https://orcid.org/0000-0002-2249-0982"]},"institutions":[{"id":"https://openalex.org/I161103922","display_name":"Philipps University of Marburg","ror":"https://ror.org/01rdrb571","country_code":"DE","type":"education","lineage":["https://openalex.org/I161103922"]},{"id":"https://openalex.org/I268975460","display_name":"Universit\u00e4tsklinikum Gie\u00dfen und Marburg","ror":"https://ror.org/032nzv584","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I268975460"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Carsten Denkert","raw_affiliation_strings":["2Institut f\u00fcr Pathologie, Philipps Universit\u00e4t Marburg und Universit\u00e4tsklinikum Marburg (UKGM), Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Institut f\u00fcr Pathologie, Philipps Universit\u00e4t Marburg und Universit\u00e4tsklinikum Marburg (UKGM), Germany","institution_ids":["https://openalex.org/I161103922","https://openalex.org/I268975460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100390862","display_name":"Yuan Liu","orcid":"https://orcid.org/0000-0002-2728-5718","observed_orcids":["https://orcid.org/0000-0002-2728-5718"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yuan Liu","raw_affiliation_strings":["3Pfizer Inc, San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Pfizer Inc, San Diego, California","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029801038","display_name":"Erik S. Knudsen","orcid":"https://orcid.org/0000-0002-5130-5969","observed_orcids":["https://orcid.org/0000-0002-5130-5969"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Erik S. Knudsen","raw_affiliation_strings":["4Roswell Park Comprehensive Cancer Center, Buffalo, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Roswell Park Comprehensive Cancer Center, Buffalo, New York","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005537242","display_name":"Angela M. DeMichele","orcid":"https://orcid.org/0000-0003-1297-4251","observed_orcids":["https://orcid.org/0000-0003-1297-4251"]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Angela DeMichele","raw_affiliation_strings":["5University of Pennsylvania, Philadelphia, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5University of Pennsylvania, Philadelphia, Pennsylvania","institution_ids":["https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100443024","display_name":"Zhe Zhang","orcid":"https://orcid.org/0000-0003-0336-4865","observed_orcids":["https://orcid.org/0000-0003-0336-4865"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zhe Zhang","raw_affiliation_strings":["6Pfizer, San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Pfizer, San Diego, California","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012509217","display_name":"Julia Teply\u2010Szymanski","orcid":"https://orcid.org/0000-0002-3880-1968","observed_orcids":["https://orcid.org/0000-0002-3880-1968"]},"institutions":[{"id":"https://openalex.org/I161103922","display_name":"Philipps University of Marburg","ror":"https://ror.org/01rdrb571","country_code":"DE","type":"education","lineage":["https://openalex.org/I161103922"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Julia Teply-Szymanski","raw_affiliation_strings":["7Philipps University Marburg, Marburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7Philipps University Marburg, Marburg, Germany","institution_ids":["https://openalex.org/I161103922"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030453966","display_name":"Martin Filipits","orcid":"https://orcid.org/0000-0003-2847-4534","observed_orcids":["https://orcid.org/0000-0003-2847-4534"]},"institutions":[{"id":"https://openalex.org/I76134821","display_name":"Medical University of Vienna","ror":"https://ror.org/05n3x4p02","country_code":"AT","type":"education","lineage":["https://openalex.org/I76134821"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"Martin Filipits","raw_affiliation_strings":["8Center for Cancer Research, Medical University of Vienna, Vienna, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"8Center for Cancer Research, Medical University of Vienna, Vienna, Austria","institution_ids":["https://openalex.org/I76134821"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017728105","display_name":"Peter Andreas Fasching","orcid":"https://orcid.org/0000-0003-4885-8471","observed_orcids":["https://orcid.org/0000-0003-4885-8471","https://orcid.org/0000-0003-1709-1079"]},"institutions":[{"id":"https://openalex.org/I4210088053","display_name":"Universit\u00e4tsklinikum Erlangen","ror":"https://ror.org/0030f2a11","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210088053"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Peter A. Fasching","raw_affiliation_strings":["9Department of Obstetrics and Gynecology, University Hospital Erlangen, Erlangen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"9Department of Obstetrics and Gynecology, University Hospital Erlangen, Erlangen, Germany","institution_ids":["https://openalex.org/I4210088053"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025718393","display_name":"Michael Gnant","orcid":"https://orcid.org/0000-0003-1002-2118","observed_orcids":["https://orcid.org/0000-0003-1002-2118"]},"institutions":[{"id":"https://openalex.org/I76134821","display_name":"Medical University of Vienna","ror":"https://ror.org/05n3x4p02","country_code":"AT","type":"education","lineage":["https://openalex.org/I76134821"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"Michael Gnant","raw_affiliation_strings":["10Medical University of Vienna, Vienna, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"10Medical University of Vienna, Vienna, Austria","institution_ids":["https://openalex.org/I76134821"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002187013","display_name":"Shibing Deng","orcid":"https://orcid.org/0000-0002-2867-263X","observed_orcids":["https://orcid.org/0000-0002-2867-263X"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shibing Deng","raw_affiliation_strings":["11Pfizer, San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"11Pfizer, San Diego, California","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086400759","display_name":"Marija Bali\u0107","orcid":"https://orcid.org/0000-0001-9482-9191","observed_orcids":["https://orcid.org/0000-0001-9482-9191"]},"institutions":[{"id":"https://openalex.org/I202276237","display_name":"Medical University of Graz","ror":"https://ror.org/02n0bts35","country_code":"AT","type":"education","lineage":["https://openalex.org/I202276237"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"Marija Balic","raw_affiliation_strings":["12Divison of Oncology, Department of Internal Medicine, Medical University Graz, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"12Divison of Oncology, Department of Internal Medicine, Medical University Graz, Austria","institution_ids":["https://openalex.org/I202276237"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012974257","display_name":"Federico Rojo","orcid":"https://orcid.org/0000-0001-9989-0290","observed_orcids":["https://orcid.org/0000-0001-9989-0290"]},"institutions":[{"id":"https://openalex.org/I63634437","display_name":"Universidad Aut\u00f3noma de Madrid","ror":"https://ror.org/01cby8j38","country_code":"ES","type":"education","lineage":["https://openalex.org/I63634437"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Federico Rojo","raw_affiliation_strings":["13The Autonomous University of Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"13The Autonomous University of Madrid, Spain","institution_ids":["https://openalex.org/I63634437"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Mark Watson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mark Watson","raw_affiliation_strings":["14Washington University School of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"14Washington University School of Medicine","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112032109","display_name":"Chetan Deshpande","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chetan Deshpande","raw_affiliation_strings":["15Pfizer Inc., San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"15Pfizer Inc., San Diego, California","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060044961","display_name":"Nicholas C. Turner","orcid":"https://orcid.org/0000-0001-8937-0873","observed_orcids":["https://orcid.org/0000-0001-8937-0873"]},"institutions":[{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Nicholas Turner","raw_affiliation_strings":["16The Royal Marsden Hospital, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"16The Royal Marsden Hospital, London, United Kingdom","institution_ids":["https://openalex.org/I4210121186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026132340","display_name":"Otto Metzger","orcid":"https://orcid.org/0000-0003-0792-0320","observed_orcids":["https://orcid.org/0000-0003-0792-0320"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Otto Metzger","raw_affiliation_strings":["17Dana-Farber Cancer Institute, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"17Dana-Farber Cancer Institute, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113726180","display_name":"Kathy Puyana Theall","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kathy Puyana Theall","raw_affiliation_strings":["18Pfizer Inc., Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"18Pfizer Inc., Cambridge, Massachusetts","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034535391","display_name":"Agnieszka Katarzyna Witkiewicz","orcid":"https://orcid.org/0000-0003-4538-1145","observed_orcids":["https://orcid.org/0000-0003-4538-1145"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Agnieszka Witkiewicz","raw_affiliation_strings":["19Roswell Park Comprehensive Cancer Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"19Roswell Park Comprehensive Cancer Center","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040594266","display_name":"Olga Valota","orcid":"https://orcid.org/0000-0002-7583-9914","observed_orcids":["https://orcid.org/0000-0002-7583-9914"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Olga Valota","raw_affiliation_strings":["20Pfizer Srl, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"20Pfizer Srl, Milan, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001315712","display_name":"W. Fraser Symmans","orcid":"https://orcid.org/0000-0002-1526-184X","observed_orcids":["https://orcid.org/0000-0002-1526-184X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"W. Fraser Symmans","raw_affiliation_strings":["21UT MD Anderson Cancer Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"21UT MD Anderson Cancer Center","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111775802","display_name":"Erica L. Mayer","orcid":"https://orcid.org/0000-0001-5430-8957","observed_orcids":["https://orcid.org/0000-0001-5430-8957"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Erica L. Mayer","raw_affiliation_strings":["22Dana-Farber Cancer Institute, Boston, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"22Dana-Farber Cancer Institute, Boston, United States","institution_ids":["https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":13,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"83","issue":"5_Supplement","first_page":"PD17","last_page":"05"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.8148999810218811,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.8148999810218811,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.18289999663829803,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/palbociclib","display_name":"palbociclib","score":0.9980000257492065},{"id":"https://openalex.org/keywords/endocrine-therapy","display_name":"endocrine therapy","score":0.9120000004768372},{"id":"https://openalex.org/keywords/early-breast-cancer","display_name":"early breast cancer","score":0.9850000143051147},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.8090000152587891},{"id":"https://openalex.org/keywords/composite-biomarker","display_name":"composite biomarker","score":0.7350000143051147},{"id":"https://openalex.org/keywords/pallas-trial","display_name":"PALLAS trial","score":1.0},{"id":"https://openalex.org/keywords/invasive-disease-free-survival","display_name":"invasive disease-free survival","score":0.7459999918937683},{"id":"https://openalex.org/keywords/pam50-subtypes","display_name":"PAM50 molecular subtypes","score":0.6579999923706055},{"id":"https://openalex.org/keywords/luminal-a-subtype","display_name":"luminal A","score":0.6389999985694885},{"id":"https://openalex.org/keywords/luminal-b","display_name":"luminal B","score":0.75},{"id":"https://openalex.org/keywords/cdk4-6-inhibitors","display_name":"CDK4/6 inhibitors","score":0.5839999914169312},{"id":"https://openalex.org/keywords/gene-expression-profiling","display_name":"gene expression profiling","score":0.5730000138282776},{"id":"https://openalex.org/keywords/treatment-response-prediction","display_name":"treatment response prediction","score":0.44600000977516174},{"id":"https://openalex.org/keywords/biomarker-validation","display_name":"biomarker validation","score":0.4490000009536743}],"concepts":[{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.7470076084136963},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6588613390922546},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6227188110351562},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5815479159355164},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5090426802635193},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4960812032222748},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.4950386583805084},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.4744240641593933},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.29199498891830444},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.12252643704414368},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.07689017057418823}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.sabcs22-pd17-05","doi":"https://doi.org/10.1158/1538-7445.sabcs22-pd17-05","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.sabcs22-pd17-05","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4322769163","https://openalex.org/W3167059951","https://openalex.org/W4399121891","https://openalex.org/W2944783636","https://openalex.org/W4412125742","https://openalex.org/W4411289789","https://openalex.org/W4221105649","https://openalex.org/W4396590899","https://openalex.org/W2805079852","https://openalex.org/W2760817089"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"The":[2,269,349,373],"PENELOPE-B":[3,123,266,274,355,479],"(NCT01864746)":[4],"and":[5,167,172,184,199,220,233,246,267,462,480],"PALLAS":[6,161,234,301,481],"(NCT02513394)":[7],"trials":[8,15,403],"are":[9],"large":[10],"prospective,":[11],"randomized,":[12],"phase":[13],"III":[14],"that":[16,143],"evaluated":[17],"adjuvant":[18,401],"palbociclib":[19],"(PAL)":[20],"+":[21,68,284,314,471],"endocrine":[22],"treatment":[23,118,188,198,333,405],"(ET)":[24],"vs":[25],"ET":[26,69,285,315],"in":[27,70,122,214,273,324,359,475],"patients":[28,62,230,329,369,381],"with":[29,125,139,164,211,275],"hormone":[30,407],"receptor\u2013positive/human":[31],"epidermal":[32],"growth":[33],"factor":[34],"receptor":[35],"2\u2013negative":[36],"(HER2\u2013)":[37],"early":[38],"breast":[39],"cancer":[40],"(EBC).":[41],"Both":[42],"studies":[43],"did":[44],"not":[45,323],"meet":[46],"the":[47,87,101,104,129,145,179,193,217,221,300,304,325,328,342,385,487],"primary":[48],"endpoint":[49],"of":[50,229,299,327,346,365,368,379,387,406,464,469,486],"improving":[51],"invasive":[52],"disease-free":[53],"survival":[54],"(iDFS).":[55],"We":[56],"conducted":[57,85,159],"biomarker":[58,200,222,352,375],"analyses":[59,83],"to":[60,148,389,399],"identify":[61],"who":[63],"might":[64],"benefit":[65,281,311,383],"from":[66,78,100,282,312,354,371,384],"PAL":[67,283,313,388],"EBC.":[71,409],"Methods:":[72],"Resected":[73],"tumor":[74],"tissue":[75,166],"was":[76,158,202,356],"collected":[77],"consenting":[79],"patients.":[80],"Gene":[81],"expression":[82],"were":[84,108,120,176,190,208],"using":[86,110,132,178,192,303],"HTG":[88,102,168],"EdgeSeq":[89],"Oncology":[90],"Biomarker":[91,467],"Panel":[92],"including":[93],"2549":[94],"genes.":[95],"Based":[96],"on":[97,137,160],"91":[98],"genes":[99],"panel,":[103],"intrinsic":[105],"molecular":[106],"subtypes":[107,239,257],"calculated":[109,177],"Absolute":[111],"Intrinsic":[112],"Molecular":[113],"Subtyping":[114],"(AIMS).":[115],"Potential":[116],"predictive":[117,351],"biomarkers":[119],"established":[121],"(n=906":[124],"resected":[126,165],"tissue)":[127],"as":[128],"development":[130],"set":[131,219,223],"an":[133],"outcome-oriented":[134],"approach":[135,394],"based":[136],"iDFS":[138,185,215,264],"a":[140,150,252,279,309,360,366,377,465],"selection":[141],"procedure":[142],"maximized":[144],"log-rank":[146,194],"statistic":[147],"estimate":[149],"standard":[151],"Z":[152],"score\u2013based":[153],"optimal":[154,276,306],"cutoff.":[155],"Independent":[156,297],"validation":[157,298],"(n=2085;":[162],"PENELOPE-B-like":[163],"data).":[169],"Hazard":[170],"ratios":[171],"corresponding":[173],"95%":[174],"CIs":[175],"Cox":[180],"proportional":[181],"hazards":[182],"model,":[183],"distributions":[186],"between":[187,197,216,265],"arms":[189],"compared":[191],"test.":[195],"Interaction":[196],"status":[201],"assessed.":[203],"Results:":[204],"Patient":[205],"baseline":[206],"characteristics":[207],"well":[209],"balanced,":[210],"no":[212],"differences":[213],"intent-to-treat":[218],"for":[224,263,341,404],"both":[225],"trials.":[226],"Approximately":[227],"73%":[228],"(PENELOPE-B":[231,244],"[n=663]":[232],"[n=1516])":[235],"had":[236,251],"luminal":[237,253],"A":[238],"whereas":[240],"only":[241],"7.1":[242],"%":[243,248],"[n=64])":[245],"8.3":[247],"(PALLAS":[249],"[n=172])":[250],"B":[254],"subtype.":[255],"AIMS":[256],"showed":[258],"overall":[259],"similar":[260],"prognostic":[261],"patterns":[262],"PALLAS.":[268,347,372],"biomarker-defined":[270],"subgroup":[271,302],"found":[272],"cutoff":[277,307],"demonstrated":[278],"preferential":[280],"(n=364":[286],"[96":[287],"events];":[288,318],"hazard":[289],"ratio":[290],"[95%":[291],"CI],":[292],"0.63":[293],"[0.42,":[294],"0.95];":[295],"P=0.025).":[296],"pre-defined":[305],"confirmed":[308],"significant":[310],"(n=916":[316],"[70":[317],"0.55":[319],"[0.34\u20130.90];":[320],"P=0.015)":[321,338],"while":[322],"rest":[326],"(interaction":[330],"p=0.0025).":[331],"Significant":[332],"effects":[334],"remained":[335],"(0.55":[336],"[0.34\u20130.89];":[337],"after":[339],"adjusting":[340],"randomization":[343],"stratification":[344,393],"factors":[345],"Conclusions:":[348],"composite":[350,374],"defined":[353,362],"independently":[357],"validated":[358],"prospectively":[361],"retrospective":[363],"analysis":[364],"subset":[367,378],"selected":[370],"identified":[376],"EBC":[380],"deriving":[382],"addition":[386],"ET.":[390],"This":[391],"patient":[392],"can":[395],"potentially":[396],"be":[397],"applied":[398],"future":[400],"clinical":[402],"receptor\u2013positive/HER2\u2013":[408],"Citation":[410],"Format:":[411],"Sibylle":[412],"Loibl,":[413],"Carsten":[414],"Denkert,":[415],"Yuan":[416],"Liu,":[417],"Erik":[418],"S.":[419],"Knudsen,":[420],"Angela":[421],"DeMichele,":[422],"Zhe":[423],"Zhang,":[424],"Julia":[425],"Teply-Szymanski,":[426],"Martin":[427],"Filipits,":[428],"Peter":[429],"A.":[430],"Fasching,":[431],"Michael":[432],"Gnant,":[433],"Shibing":[434],"Deng,":[435],"Marija":[436],"Balic,":[437],"Federico":[438],"Rojo,":[439],"Mark":[440],"Watson,":[441],"Chetan":[442],"Deshpande,":[443],"Nicholas":[444],"Turner,":[445],"Otto":[446],"Metzger,":[447],"Kathy":[448],"Puyana":[449],"Theall,":[450],"Agnieszka":[451],"Witkiewicz,":[452],"Olga":[453],"Valota,":[454],"W.":[455],"Fraser":[456],"Symmans,":[457],"Erica":[458],"L.":[459],"Mayer.":[460],"Development":[461],"Validation":[463],"Composite":[466],"Predictive":[468],"Palbociclib":[470],"Endocrine":[472],"Treatment":[473],"Benefit":[474],"Early":[476],"Breast":[477,491],"Cancer:":[478],"Trials":[482],"[abstract].":[483],"In:":[484],"Proceedings":[485],"2022":[488,494],"San":[489,497],"Antonio":[490],"Cancer":[492,503],"Symposium;":[493],"Dec":[495],"6-10;":[496],"Antonio,":[498],"TX.":[499],"Philadelphia":[500],"(PA):":[501],"AACR;":[502],"Res":[504],"2023;83(5":[505],"Suppl):Abstract":[506],"nr":[507],"PD17-05.":[508]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2023,"cited_by_count":1}],"updated_date":"2026-10-17T09:40:24.721904","created_date":"2023-03-03T00:00:00"}